CIK 0001114483 · Large accelerated filer
Integer Holdings Corp
Sign in to watch- Ticker
- ITGR
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161531026
- Phone
- (214) 618-5243
- Business address
- 5830 GRANITE PARKWAY., SUITE 1150, PLANO, TX, 75024
- Former names
- GREATBATCH, INC., WILSON GREATBATCH TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,169,956
- in 2 filings
Net −$5,169,956. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-24 | Blackwood Lindsay K. SVP, Gen Counsel & Secretary | Option exercise · Restricted Stock Units | −1,777 | 3,556 | ||
| 2026-03-24 | Blackwood Lindsay K. SVP, Gen Counsel & Secretary | Option exercise · Restricted Stock Units | −1,706 | 1,707 | ||
| 2026-03-13 | Thomas Tommy P VP, Corporate Controller | Sale | −825 | $85.00 | $70K | 4,381 |
| 2026-03-12 | Kapito Aaron Director | Grant or award | +410 | 1,370.68 | ||
| 2026-03-12 | Flanagan James Francis Director | Grant or award | +410 | 410 | ||
| 2026-02-24 | Khales Payman President & CEO | Option exercise | +16,077 | 51,816 | ||
| 2026-02-24 | Khales Payman President & CEO | Option exercise | +26,983 | 78,799 | ||
| 2026-02-24 | Khales Payman President & CEO | Shares withheld for taxes | −16,945 | $87.10 | $1.5M | 61,854 |
| 2026-02-24 | Khales Payman President & CEO | Option exercise · Restricted Stock Units | −16,077 | 0 | ||
| 2026-02-24 | Khales Payman President & CEO | Option exercise · Restricted Stock Units | −26,983 | 0 | ||
| 2026-02-20 | Stephens Jim President, CRM & Neuro | Grant or award | +2,691 | 5,024 | ||
| 2026-02-20 | Stephens Jim President, CRM & Neuro | Shares withheld for taxes | −656 | $84.85 | $56K | 4,368 |
| 2026-02-20 | Smith Diron EVP, Chief Financial Officer | Grant or award | +798 | 10,935.83 | ||
| 2026-02-20 | Smith Diron EVP, Chief Financial Officer | Grant or award | +817 | 11,752.83 | ||
| 2026-02-20 | Smith Diron EVP, Chief Financial Officer | Shares withheld for taxes | −394 | $84.85 | $33K | 11,358.83 |
| 2026-02-20 | Senn Andrew President, Cardio & Vascular | Grant or award | +2,340 | 13,880 | ||
| 2026-02-20 | Senn Andrew President, Cardio & Vascular | Grant or award | +2,380 | 16,260 | ||
| 2026-02-20 | Senn Andrew President, Cardio & Vascular | Shares withheld for taxes | −1,447 | $84.85 | $123K | 14,813 |
| 2026-02-20 | Khales Payman President & CEO | Grant or award | +7,389 | 32,861 | ||
| 2026-02-20 | Khales Payman President & CEO | Grant or award | +7,516 | 40,377 |
Page 3 of 17 · 335 trades